# Pre-calibrated susceptibility and clinical fraction

# Consensus fitting
u = repeat([0.39, 0.38, 0.79, 0.87, 0.80, 0.82, 0.89, 0.74], inner=2)
y = repeat([0.28, 0.20, 0.26, 0.33, 0.40, 0.49, 0.63, 0.69], inner=2)

# Parametric fitting
#u = [0.017781719 0.017781719 0.017781719 0.01826781 0.022270941 0.02828467 0.036056645 0.042069826 0.046073505 0.049071611 0.053326546 0.060093496 0.067362959 0.070109808 0.070595351 0.070595351]
#y = fill(0.5, 16)
#u = fill(1, 16)
#y = [0.143576826 0.143576826 0.143576826 0.14861461 0.17884131 0.231738035 0.294710327 0.34256927 0.375314861 0.400503778 0.435768262 0.496221662 0.549118388 0.571788413 0.576826196 0.579345088]


# Hospitalization proportion (Walker et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science)
hr = [0.001 0.001 0.001 0.002 0.005 0.010 0.016 0.023 0.029 0.039 0.058 0.072 0.102 0.117 0.146 0.177]

# Infection-fatality rate (Cauchemez et al)
mr = [0.0029779793249023944 0.0006902074129525008 0.0010986456593059498 0.0025712141464285677 0.00788016120723863 0.01707126787441296 0.03295067938768822 0.05450548855770153 0.10520559407459301 0.16747709571380626 0.2992292800713443 0.45833632052172846 0.6017003863908792 1.5208806528464696 2.420879428727841 4.325739774854706] / 100


# Empty contact matrix
c = zeros(16,16)

# Relative infectiousness of sub-clinical cases
f = 0.5

# Sojourn times in each infected state
te = 3.0
tp = 2.1
tc = 2.9
ts = 5.0

# Susceptible population
S = ones(16)
N0 = S

# Pre-existing immunity
pre = fill(0, 16)
# Eigenvector for UK NGM (scaled):  
#pre = [0.1606550965567705, 0.24741019844344658, 0.24675699271099463 ,0.24680452313198686, 0.23166066487672166, 0.2846001016658788, 0.27813484625038737, 0.2915186471628544, 0.3005415934564901, 0.31421719950695987, 0.259275828996101, 0.2800159452672984, 0.2171807295271507, 0.20925181216387498, 0.17946700256146056, 0.21855016179936498]
# UK Serological study (Scaled)
#pre = [0.3115827594955387, 0.3115827594955387, 0.3115827594955387, 0.3115827594955387, 0.3115827594955387, 0.3115827594955387, 0.2551755357937601, 0.2551755357937601, 0.23368706962165398, 0.23368706962165398, 0.23368706962165398, 0.23368706962165398, 0.18802407900592852, 0.18802407900592852, 0.16384955456230912, 0.16384955456230912]
# China and India
#pre = fill(0.25, 16)

# Scaling factor for NGM (i.e. probability of transmission given contact)
sf = 1

# Baseline vaccine efficacy
#e = 0.7
e = 0.9

# Relative efficacy in 60+ age groups
re = 1.0
#re = 0.5

p_base = (;u,y,hr,mr,c,f,te,tp,tc,ts,S,N0,pre,sf,e,re)

